Literature DB >> 14633637

Unusual apoptosis in experimental cardiac rejection.

Jiri T Beranek.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14633637      PMCID： PMC1892358          DOI： 10.1016/s0002-9440(10)63620-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  13 in total

Review 1.  Neutrophil-derived proteins: selling cytokines by the pound.

Authors:  M A Cassatella
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

2.  The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection.

Authors:  H Wang; M E DeVries; S Deng; M H Khandaker; J G Pickering; L H Chow; B Garcia; D J Kelvin; R Zhong
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  Quick disposal of dead cardiomyocytes: an ultimate proof of apoptosis.

Authors:  J T Beranek
Journal:  J Heart Lung Transplant       Date:  2001-08       Impact factor: 10.247

4.  Tissue factor identifies cardiomyocyte apoptotic bodies in reperfusion injury.

Authors:  Jiri T Beranek
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo.

Authors:  Peiyee Lee; Masataka Sata; David J Lefer; Stephen M Factor; Kenneth Walsh; Richard N Kitsis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10-31       Impact factor: 4.733

6.  Further evidence of cardiomyocyte apoptosis in hyperacute rejection.

Authors:  J T Beranek
Journal:  J Heart Lung Transplant       Date:  2002-06       Impact factor: 10.247

7.  Pathogenesis of postinfarction free wall rupture.

Authors:  Jiri T Beranek
Journal:  Int J Cardiol       Date:  2002-07       Impact factor: 4.164

8.  Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.

Authors:  D K Bishop; S Chan Wood; E J Eichwald; C G Orosz
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

9.  IFN-gamma alters the pathology of graft rejection: protection from early necrosis.

Authors:  P F Halloran; L W Miller; J Urmson; V Ramassar; L F Zhu; N M Kneteman; K Solez; M Afrouzian
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

10.  Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis.

Authors:  P F Halloran; M Afrouzian; V Ramassar; J Urmson; L F Zhu; L M Helms; K Solez; N M Kneteman
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.